Cargando…

Prevalence of Polycystic Ovary Syndrome amongst Females Aged between 15 and 45 Years at a Major Women’s Hospital in Dubai, United Arab Emirates

Objective criteria have been scarce in published data on the occurrence of polycystic ovary syndrome (PCOS) in the United Arab Emirates (UAE). It is crucial that we enhance our comprehension of PCOS prevalence in the UAE to inform key stakeholders about the disease’s burden and enable comparisons wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Mirza, Fadi G., Tahlak, Muna A., Hazari, Komal, Khamis, Amar Hassan, Atiomo, William
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10178028/
https://www.ncbi.nlm.nih.gov/pubmed/37174235
http://dx.doi.org/10.3390/ijerph20095717
_version_ 1785040762657832960
author Mirza, Fadi G.
Tahlak, Muna A.
Hazari, Komal
Khamis, Amar Hassan
Atiomo, William
author_facet Mirza, Fadi G.
Tahlak, Muna A.
Hazari, Komal
Khamis, Amar Hassan
Atiomo, William
author_sort Mirza, Fadi G.
collection PubMed
description Objective criteria have been scarce in published data on the occurrence of polycystic ovary syndrome (PCOS) in the United Arab Emirates (UAE). It is crucial that we enhance our comprehension of PCOS prevalence in the UAE to inform key stakeholders about the disease’s burden and enable comparisons with other nations. This research aimed to examine the PCOS prevalence at a large academic tertiary centre in Dubai, UAE, called Latifa Women and Children’s Hospital. We performed a cross-sectional study by reviewing the electronic medical records of patients accessing care between 2017 and 2022 (5 years). By utilizing the international classification of diseases codes (ICD-10), we discovered a period prevalence of PCOS of 1.6% among 64,722 women aged between 15 and 45 years. It is worth noting that the estimated annual point prevalence rose from 1.19% in 2020 (at the beginning of the COVID19 pandemic) to 2.72% in 2022 (after the start of the COVID-19 pandemic). Therefore, the odds ratio of the risk of a PCOS diagnosis in 2022 compared to 2020 was 2.28. The majority of the women diagnosed with PCOS in this study had an ICD-10 code of E28.2. Women with PCOS were younger than the controls, less likely to be pregnant, and had a higher body mass index and systolic and diastolic blood pressure. This is the most extensive research to date examining PCOS prevalence in the UAE, and it emphasizes the significance of this condition. It is crucial to prioritize PCOS to prevent morbidity and mortality from reproductive and long-term health consequences, including infertility, type 2 diabetes and endometrial cancer, which is presently the most frequent gynecological cancer in the UAE.
format Online
Article
Text
id pubmed-10178028
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-101780282023-05-13 Prevalence of Polycystic Ovary Syndrome amongst Females Aged between 15 and 45 Years at a Major Women’s Hospital in Dubai, United Arab Emirates Mirza, Fadi G. Tahlak, Muna A. Hazari, Komal Khamis, Amar Hassan Atiomo, William Int J Environ Res Public Health Article Objective criteria have been scarce in published data on the occurrence of polycystic ovary syndrome (PCOS) in the United Arab Emirates (UAE). It is crucial that we enhance our comprehension of PCOS prevalence in the UAE to inform key stakeholders about the disease’s burden and enable comparisons with other nations. This research aimed to examine the PCOS prevalence at a large academic tertiary centre in Dubai, UAE, called Latifa Women and Children’s Hospital. We performed a cross-sectional study by reviewing the electronic medical records of patients accessing care between 2017 and 2022 (5 years). By utilizing the international classification of diseases codes (ICD-10), we discovered a period prevalence of PCOS of 1.6% among 64,722 women aged between 15 and 45 years. It is worth noting that the estimated annual point prevalence rose from 1.19% in 2020 (at the beginning of the COVID19 pandemic) to 2.72% in 2022 (after the start of the COVID-19 pandemic). Therefore, the odds ratio of the risk of a PCOS diagnosis in 2022 compared to 2020 was 2.28. The majority of the women diagnosed with PCOS in this study had an ICD-10 code of E28.2. Women with PCOS were younger than the controls, less likely to be pregnant, and had a higher body mass index and systolic and diastolic blood pressure. This is the most extensive research to date examining PCOS prevalence in the UAE, and it emphasizes the significance of this condition. It is crucial to prioritize PCOS to prevent morbidity and mortality from reproductive and long-term health consequences, including infertility, type 2 diabetes and endometrial cancer, which is presently the most frequent gynecological cancer in the UAE. MDPI 2023-05-04 /pmc/articles/PMC10178028/ /pubmed/37174235 http://dx.doi.org/10.3390/ijerph20095717 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Mirza, Fadi G.
Tahlak, Muna A.
Hazari, Komal
Khamis, Amar Hassan
Atiomo, William
Prevalence of Polycystic Ovary Syndrome amongst Females Aged between 15 and 45 Years at a Major Women’s Hospital in Dubai, United Arab Emirates
title Prevalence of Polycystic Ovary Syndrome amongst Females Aged between 15 and 45 Years at a Major Women’s Hospital in Dubai, United Arab Emirates
title_full Prevalence of Polycystic Ovary Syndrome amongst Females Aged between 15 and 45 Years at a Major Women’s Hospital in Dubai, United Arab Emirates
title_fullStr Prevalence of Polycystic Ovary Syndrome amongst Females Aged between 15 and 45 Years at a Major Women’s Hospital in Dubai, United Arab Emirates
title_full_unstemmed Prevalence of Polycystic Ovary Syndrome amongst Females Aged between 15 and 45 Years at a Major Women’s Hospital in Dubai, United Arab Emirates
title_short Prevalence of Polycystic Ovary Syndrome amongst Females Aged between 15 and 45 Years at a Major Women’s Hospital in Dubai, United Arab Emirates
title_sort prevalence of polycystic ovary syndrome amongst females aged between 15 and 45 years at a major women’s hospital in dubai, united arab emirates
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10178028/
https://www.ncbi.nlm.nih.gov/pubmed/37174235
http://dx.doi.org/10.3390/ijerph20095717
work_keys_str_mv AT mirzafadig prevalenceofpolycysticovarysyndromeamongstfemalesagedbetween15and45yearsatamajorwomenshospitalindubaiunitedarabemirates
AT tahlakmunaa prevalenceofpolycysticovarysyndromeamongstfemalesagedbetween15and45yearsatamajorwomenshospitalindubaiunitedarabemirates
AT hazarikomal prevalenceofpolycysticovarysyndromeamongstfemalesagedbetween15and45yearsatamajorwomenshospitalindubaiunitedarabemirates
AT khamisamarhassan prevalenceofpolycysticovarysyndromeamongstfemalesagedbetween15and45yearsatamajorwomenshospitalindubaiunitedarabemirates
AT atiomowilliam prevalenceofpolycysticovarysyndromeamongstfemalesagedbetween15and45yearsatamajorwomenshospitalindubaiunitedarabemirates